Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Using novel blood biomarkers to investigate associations of vascular risk, Alzheimer’s pathology, and brain health across neurological diseases
FY 2021-22
Summary
Dementia is a pressing concern given Canadas aging population coupled with the lack of effective treatments for dementia-causing disorders. Vascular risk factors (e.g., diabetes, high cholesterol, high blood pressure) are common in older adults, and are associated with increased risk for cognitive decline and dementia. Research has shown that when vascular risk factors and Alzheimers pathology occur together, older adults experience more rapid cognitive decline and brain volume loss. Interestingly, Alzheimers pathology is commonly observed in the brains of older adults with non-Alzheimer's neurological disorders, such as Parkinsons disease and cerebrovascular disease. However, it is currently not known how Alzheimers pathology and vascular risk factors affect cognition and brain volume loss in these conditions. Recently developed technology now allows for the proteins associated with Alzheimers disease (i.e., amyloid and tau) to be measured in the blood. In this study, I will leverage this novel technology to measure Alzheimer's pathology non-invasively in an Ontario-wide study of participants with Parkinson's disease and cerebrovascular disease. The main goal of this study is to determine whether Alzheimer's pathology and vascular risk are associated with accelerated cognitive decline and brain volume loss in these conditions. The results of this study will provide new insight into risk factors for cognitive decline in Parkinsons disease and cerebrovascular disease. If vascular risk contributes to cognitive decline and brain volume loss across multiple neurological diseases, vascular health could be targeted to prevent and slow the progression of dementia for the many Canadians at risk.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
466500
Name
Wood Alexander Madeline
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Using novel blood biomarkers to investigate associations of vascular risk, Alzheimer’s pathology, and brain health across neurological diseases
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Alzheimer'S Disease; Amyloid; Blood Biomarkers; Cerebrovascular Disease; Cognitive Decline; Dementia; Neurodegeneration; Parkinson'S Disease; Tau; Vascular Risk
Abstract
Dementia is a pressing concern given Canadas aging population coupled with the lack of effective treatments for dementia-causing disorders. Vascular risk factors (e.g., diabetes, high cholesterol, high blood pressure) are common in older adults, and are associated with increased risk for cognitive decline and dementia. Research has shown that when vascular risk factors and Alzheimers pathology occur together, older adults experience more rapid cognitive decline and brain volume loss. Interestingly, Alzheimers pathology is commonly observed in the brains of older adults with non-Alzheimer's neurological disorders, such as Parkinsons disease and cerebrovascular disease. However, it is currently not known how Alzheimers pathology and vascular risk factors affect cognition and brain volume loss in these conditions. Recently developed technology now allows for the proteins associated with Alzheimers disease (i.e., amyloid and tau) to be measured in the blood. In this study, I will leverage this novel technology to measure Alzheimer's pathology non-invasively in an Ontario-wide study of participants with Parkinson's disease and cerebrovascular disease. The main goal of this study is to determine whether Alzheimer's pathology and vascular risk are associated with accelerated cognitive decline and brain volume loss in these conditions. The results of this study will provide new insight into risk factors for cognitive decline in Parkinsons disease and cerebrovascular disease. If vascular risk contributes to cognitive decline and brain volume loss across multiple neurological diseases, vascular health could be targeted to prevent and slow the progression of dementia for the many Canadians at risk.
Competitiondate
202112
Approvedterm2
1 yr 0 mth
Pinamesdelim
Wood Alexander, Madeline
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~